BeyondSpring Announces Final Positive Data from the PROTECTIVE-1 Phase 3 CIN Program of Plinabulin as a Single Agent Compared to Pegfilgrastim at the American Society of Clinical Oncology (ASCO) Annual Meeting

Brenda Snow
Authentic Patient Voice

Paul Theisen
Patient Acquisition

Joey Cohen
Medication Adherence

Pat Purcell
Meeting Engagement

Suma Ramadas, PhD
Medical Affairs

Matthew Durham
Omnidynamic Marketing

Amy Giles
Increasing Engagement

Matt Turner
Patient Affordability

Bud Bilanich
Success Coach

Liz Kane
Impactful Strategy

Frank Burrell
Scientific Storytelling

Daniel Sontupe
Market Access

David Linetsky
Point-of-Care Marketing

Stacey Gandler
Brand Nourishment